The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management

The new landscape of treatments for metastatic clear cell renal carcinoma (mRCC) is constantly expanding, but it is associated with the emergence of novel toxicities, adding to up to those observed in the tyrosine-kinase inhibitor (TKI) era. Indeed, the introduction of immune checkpoint inhibitors (...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberto, Michela, Panebianco, Martina, Aschelter, Anna Maria, Buccilli, Dorelsa, Cantisani, Carmen, Caponnetto, Salvatore, Cortesi, Enrico, d’Amuri, Sara, Fofi, Claudia, Ierinò, Debora, Maestrini, Viviana, Marchetti, Paolo, Marignani, Massimo, Stigliano, Antonio, Vivona, Luca, Santini, Daniele, Tomao, Silverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879059/
https://www.ncbi.nlm.nih.gov/pubmed/36713496
http://dx.doi.org/10.3389/fonc.2022.1026978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879059/
https://www.ncbi.nlm.nih.gov/pubmed/36713496
http://dx.doi.org/10.3389/fonc.2022.1026978

Ejemplares similares